- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/745 - Blood coagulation or fibrinolysis factors
Patent holdings for IPC class C07K 14/745
Total number of patents in this class: 714
10-year publication summary
|
48
|
45
|
52
|
50
|
49
|
51
|
25
|
26
|
25
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2706 |
22 |
| Modernatx, Inc. | 1291 |
18 |
| The Children's Hospital of Philadelphia | 803 |
17 |
| Bioverativ Therapeutics Inc. | 214 |
16 |
| Opko Biologics Ltd. | 78 |
13 |
| Immunitybio, Inc. | 426 |
13 |
| Yale University | 2421 |
12 |
| CSL Behring GmbH | 343 |
11 |
| The University of North Carolina at Chapel Hill | 2060 |
11 |
| Gladiator Biosciences, Inc. | 14 |
11 |
| CSL Limited | 255 |
10 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 294 |
10 |
| Alexion Pharmaceuticals, Inc. | 638 |
8 |
| Case Western Reserve University | 1846 |
8 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
8 |
| Amunix Pharmaceuticals, Inc. | 81 |
8 |
| Affibody AB | 114 |
7 |
| Octapharma AG | 203 |
7 |
| Baxter International Inc. | 2417 |
6 |
| Baxter Healthcare S.A. | 1841 |
6 |
| Other owners | 492 |